SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011641
Filing Date
2023-04-28
Accepted
2023-04-28 16:30:21
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A sabs20221231_10ka.htm   iXBRL 10-K/A 45627
2 EXHIBIT 23.1 ex_508389.htm EX-23.1 2865
3 EXHIBIT 31.1 ex_502109.htm EX-31.1 5482
4 EXHIBIT 31.2 ex_502110.htm EX-31.2 5743
  Complete submission text file 0001437749-23-011641.txt   288108

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sabs-20221231.xsd EX-101.SCH 4037
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sabs-20221231_def.xml EX-101.DEF 19524
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sabs-20221231_lab.xml EX-101.LAB 26072
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sabs-20221231_pre.xml EX-101.PRE 20371
10 EXTRACTED XBRL INSTANCE DOCUMENT sabs20221231_10ka_htm.xml XML 8396
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39871 | Film No.: 23867013
SIC: 2836 Biological Products, (No Diagnostic Substances)